Eikon Therapeutics Inc (EIKN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 105,301 | 129,579 |
| Marketable Securities | 231,074 | 90,932 |
| TOTAL | $348,917 | $227,889 |
| Non-Current Assets | ||
| PPE Net | 142,898 | 140,679 |
| Other Non-Current Assets | 102,919 | 122,672 |
| TOTAL | $245,817 | $263,351 |
| Total Assets | $594,734 | $491,240 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 681 | 17,578 |
| Accrued Expenses | 44,298 | 29,564 |
| TOTAL | $55,007 | $56,449 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 1,418,761 | 1,006,721 |
| TOTAL | $1,418,761 | $1,006,721 |
| Total Liabilities | $1,473,768 | $1,063,170 |
| Shareholders' Equity | ||
| Retained earnings | -920,509 | -604,941 |
| TOTAL | $-879,034 | $-571,930 |
| Total Liabilities And Equity | $594,734 | $491,240 |